Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2024-11-06 Board/Management Inform…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Board/Management Information Classification · 100% confidence The document is a notice of an upcoming Board Meeting scheduled for November 11, 2024, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2024. It is an intimation to the stock exchanges and public about the board meeting date and trading window closure. The document does not contain any financial data or results itself, nor is it a report or presentation. It is a formal announcement related to board activities, specifically the scheduling of a board meeting. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (1976 characters), and it is clearly an announcement, not the report itself.
2024-11-06 English
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve unaudited standalone ....
Board/Management Information Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled for November 11, 2024, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2024. It is an intimation to the stock exchanges and public about the meeting date and trading window closure. The document does not contain any financial data or results itself, nor is it a report or presentation. It is a regulatory announcement about a board meeting, which fits the category of Board/Management Information (MANG). The document length is short (1976 characters), and it is clearly an announcement, not a report or transcript.
2024-11-06 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the intimation of loss of a share certificate. It references regulatory compliance under SEBI regulations and mentions issuing a 'Letter of Confirmation' to the shareholder after formalities. The content is an official notification about a specific event related to share certificates, not a financial report, earnings release, or management discussion. The document length is short (1891 characters) and it serves as a regulatory announcement rather than a detailed report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-06 English
Please find attached intimation of loss of share certificate
Regulatory Filings
2024-11-06 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the intimation of loss of share certificates. It references compliance with SEBI regulations and circulars related to share certificate loss and the issuance of a 'Letter of Confirmation' to shareholders. The content is about regulatory compliance and notification rather than a financial report, management change, or shareholder meeting material. The document length is short (1864 characters) and it is an official notification to the exchange rather than a report or announcement of financial results or corporate actions like dividends or capital changes. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-23 English
Please find attached intimation of loss of share certificates
Regulatory Filings
2024-10-23 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.